Search results for: 'Preferred Destination for Clinical Trials'

The United States spends more than $3 trillion—nearly 18% of GDP—on healthcare, a massive sector. Healthcare value chain participants face dynamic environments that several trends impact, including the rise in the aging population (16.9% in 2020); chronic disease burden; regulatory challenges; integration across the care continuum; migration to val...

This research service focuses on antiviral/antiretroviral therapeutics for the treatment of HIV/AIDS. A product and pipeline assessment is provided for marketed and investigational products and combination regimens for the treatment of HIV infection. Segmentation by drug class is provided along with additional supporting information such as clinica...

24 Jun 2019  |  North America  |  Market Research

US Clinical Decision Support Systems Market, Forecast to 2024

A Growing Market with an Opportunity to be More than an Adjunct to the EHR

Infographics

×

Clinical Decision Support (CDS) systems are poised to become the user interface of choice for clinical interaction with health IT, ultimately supplanting the EHR system as the primary health IT point of interface for clinicians. This is due the fact that CDS began as a way to deliver medical content and patient information to the caregiver. Unlike ...

The immunoassay and clinical chemistry market is the highest share contributor for the total in vitro diagnostics (IVD) market. Globally valued at $28.7 billion in 2019, this market segment contributes 37.6% of the total IVD market of $76.3 billion. Within the high-medium to low analyzer segment, there are over 40 companies globally. Of these, 14 c...

The clinical laboratory testing industry will continue to experience growth in testing volumes due to the aging of the US population, patient awareness of the benefits of laboratory testing, test cost reductions, the development of advanced and specialized tests for disease detection and management, the growing awareness of early detection and prev...

Europe’s life sciences sector is approaching a defining inflection point in 2026, as major regulatory and policy reforms converge to reshape pharma, diagnostics, life sciences IT, biotechnology, and the bioeconomy. Together, these frameworks open clear growth pathways across the value chain: the Clinical Trials Regulation (CTR) and European Health ...

Adoption rates of drone platforms for medical deliveries have grown considerably following the COVID-19 pandemic, a period in which policymakers temporarily enabled the use of unmanned aerial systems (UASs) for contactless deliveries. Data gathered from these trials has helped regulators across the world develop a coherent regulatory framework capa...

This research service analyzes the global market for wearable technologies in clinical and consumer health. It discusses in detail how industry convergence and technological innovations are transitioning wearables from simple consumer devices to actionable healthcare applications—specifically in managing targeted chronic diseases such as diabetes, ...

This research examines the European PCR reagent markets for research application and clinical diagnostics in terms of the challenges faced by market participants and drivers and restraints in the industry. It also describes the end user's experience who incorporate PCR in their experimental plan. It provides a detailed study on market share analysi...